Artículos de revistas
Ciliary neurotrophic factor fused to a protein transduction domain retains full neuroprotective activity in the absence of cytokine-like side effects
Registro en:
Journal Of Neurochemistry. Wiley-blackwell Publishing, Inc, v. 109, n. 6, n. 1680, n. 1690, 2009.
0022-3042
WOS:000266268400011
10.1111/j.1471-4159.2009.06091.x
Autor
Rezende, AC
Peroni, D
Vieira, AS
Rogerio, F
Talaisys, RL
Costa, FTM
Langone, F
Skaper, SD
Negro, A
Institución
Resumen
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Ciliary neurotrophic factor (CNTF) is a multifunctional cytokine that can regulate the survival and differentiation of many types of developing and adult neurons. CNTF prevents the degeneration of motor neurons after axotomy and in mouse mutant progressive motor neuronopathy, which has encouraged trials of CNTF for human motor neuron disease. Given systemically, however, CNTF causes severe side effects, including cachexia and a marked immune response, which has limited its clinical application. The present work describes a novel approach for administering recombinant human CNTF (rhCNTF) while conserving neurotrophic activity and avoiding deleterious side effects. rhCNTF was fused to a protein transduction domain derived from the human immunodeficiency virus-1 TAT (transactivator) protein. The resulting fusion protein (TAT-CNTF) crosses the plasma membrane within minutes and displays a nuclear localization. TAT-CNTF was equipotent to rhCNTF in supporting the survival of cultured chicken embryo dorsal root ganglion neurons. Local or subcutaneous administration of TAT-CNTF, like rhCNTF rescued motor neurons from death in neonatal rats subjected to sciatic nerve transection. In contrast to subcutaneous rhCNTF, which caused a 20-30% decrease in body weight in neonatal rats between postnatal days 2 and 7 together with a considerable fat mobilization in brown adipose tissue, TAT-CNTF lacked such side effects. Together, these results indicate that rhCNTF fused with the protein transduction domain/TAT retains neurotrophic activity in the absence of CNTFs cytokine-like side effects and may be a promising candidate for the treatment of motor neuron and other neurodegenerative diseases. 109 6 1680 1690 Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) ASV [05/57335-6] Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) FAPESP [05/54613-7, 04/14210-8] CNPq [473909/2004-9] ASV [05/57335-6]
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Diseases, injuries, and risk factors in child and adolescent health, 1990 to 2017 findings from the global burden of diseases, injuries, and risk factors 2017 study
Robert C., Reiner Jr; Olsen, Helen Elizabeth; Ikeda, Chad Thomas; Echko, Michelle M.; Ballestreros, Katherine E.; Manguerra, Helen; Martopullo, Ira; Millear, Anoushka; Shields, Chloe; Alvis-Guzman, Nelson